SuperworthLENZ Therapeutics shares outstanding LENZ
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 31.4M
- On a year earlier
- +11.7%
- more shares
LENZ Therapeutics had 31.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 11.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 31.1M | +13% |
| FY2024 | 27.5M | +1297% |
| FY2023 | 2M | −75% |
| FY2022 | 8M | +4% |
| FY2021 | 7.6M | +1470% |
| FY2020 | 486K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 31.4M | +12% | |
| Q1 FY26 | 31.4M | +14% | |
| Q4 FY25 | 31.1M | +13% | |
| Q3 FY25 | 28.5M | +5% | |
| Q2 FY25 | 28.1M | +10% | |
| Q1 FY25 | 27.5M | +483% | |
| Q4 FY24 | 27.5M | +1297% | |
| Q3 FY24 | 27.2M | +1285% | |
| Q2 FY24 | 25.6M | +1209% | |
| Q1 FY24 | 4.7M | +142% | |
| Q4 FY23 | 2M | −75% | |
| Q3 FY23 | 2M | −75% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on LENZ Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.